CAS 280773-17-3 of Betrixaban Maleate | Chemical | Intermediates | Manufactured | Supplied

Ami Organics

VISIT THE VIRTUAL BOOTH, Contact Details

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 15 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

4 All APIs, 4 USDMF

INTERMEDIATES

240 ALL Intermediates

240 ALL Intermediates

Xls

Filters

FILTER :

filter Company Name Reset all filters

3 All

01 1Ami Organics Private Limited

02 1Cangzhou Senary Chemical Science-tech Co., Ltd

03 1Srini Pharmaceuticals

filter CAS Number Reset all filters

filter Country Reset all filters

List of Suppliers

Contact Supplier

Reset Filter

Supplier Virtual Booth

Ask Us

01

2-AMINO-N-(5-CHLOROPYRIDIN-2-YL)-5-METHOXYBENZAMIDE

India

GRx+Biosims

Not Confirmed

Cangzhou Senary Chemical Science-tech Co., Ltd

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

India

Virtual Booth

Digital Content

2-amino-N-(5-chloropyridin-2-yl)-5-methoxybenzamide

Intermediate Web Link

Market Place

CAS Number

280773-17-3

End Use API

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary ...

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.